Ingrid Hofland
The Netherlands Cancer Institute(NL)Oncode Institute(NL)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Histone Deacetylase Inhibitors Research, Click Chemistry and Applications, Protein Degradation and Inhibitors, Synthesis of Tetrazole Derivatives
Most-Cited Works
- → Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma(2014)899 cited
- → An α‐E‐catenin (CTNNA1) mutation in hereditary diffuse gastric cancer(2012)219 cited
- → Identification of recurrent FGFR3 fusion genes in lung cancer through kinome‐centred RNA sequencing(2013)118 cited
- → Androgen receptor signalling in macrophages promotes TREM-1-mediated prostate cancer cell line migration and invasion(2020)117 cited
- → Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial(2024)53 cited
- → Online measurement of oxygen consumption by goat bone marrow stromal cells in a combined cell‐seeding and proliferation perfusion bioreactor(2006)44 cited
- → Parallel high-resolution confocal Raman SEM analysis of inorganic and organic bone matrix constituents(2005)31 cited
- → A Proof-of-Concept Study of Sequential Treatment with the HDAC Inhibitor Vorinostat following BRAF and MEK Inhibitors in BRAF V600 -Mutated Melanoma(2024)11 cited
- → Exertional dyspnoea in patients with airway obstruction, with and without CO2 retention(1998)11 cited
- → High CD8 + tumour‐infiltrating lymphocyte density associates with unfavourable prognosis in oesophageal adenocarcinoma following poor response to neoadjuvant chemoradiotherapy(2021)9 cited